Frequency domain diffuse optical spectroscopy and diffuse correlation spectroscopy for assessing inspiratory muscle metabolism in mechanically ventilated patients

Information

  • Research Project
  • 10194837
  • ApplicationId
    10194837
  • Core Project Number
    R21EB031250
  • Full Project Number
    1R21EB031250-01
  • Serial Number
    031250
  • FOA Number
    PAR-18-433
  • Sub Project Id
  • Project Start Date
    9/15/2021 - 3 years ago
  • Project End Date
    6/30/2023 - a year ago
  • Program Officer Name
    ANDERSON, AFROUZ AZARI
  • Budget Start Date
    9/15/2021 - 3 years ago
  • Budget End Date
    6/30/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
  • Award Notice Date
    9/6/2021 - 3 years ago
Organizations

Frequency domain diffuse optical spectroscopy and diffuse correlation spectroscopy for assessing inspiratory muscle metabolism in mechanically ventilated patients

PROJECT SUMMARY Mechanical ventilation (MV), which is used to assist or replace spontaneous breathing in critically ill patients, led to $27 billion in expenditures in the US in 2010, accounting for 12% of all hospital costs. In that same year there were 2.7 episodes of MV per 1000 population, highlighting the enormous importance of this procedure. The COVID-19 pandemic has substantially increased these numbers, although precise rates are not yet available. MV is used, in part, to ?unload?, or reduce the metabolic effort of respiratory muscles in order to redirect oxygen delivery to vital organs. As the patients? conditions improve, key inspiratory muscles (e.g. diaphragm, scalenes, sternomastoid, etc.) need to take over spontaneous breathing independent of the ventilator. This ?reloading? is precarious due to muscle disuse atrophy, induced by unloading. This is further complicated by other common conditions such as septic or cardiogenic shock, which can severely limit oxygen delivery independent of muscle status. What?s needed is a methodology that can continuously monitor blood flow and oxygen utilization of inspiratory muscles so that respiratory effort can be continuously optimized during MV. This project aims to develop a comprehensive blood flow index, oxygenation, and metabolic measurement platform for inspiratory muscle physiology by integrating wideband frequency-domain diffuse optical spectroscopy (wbDOS) and diffuse correlation spectroscopy (DCS) to tackle this unmet need. wbDOS is a new all-digital frequency-domain DOS technique that captures amplitude and phase measurements over a wide bandwidth of modulation frequencies (50-500 MHz) at high speeds (>100 Hz). wbDOS and DCS will combine synergistically to provide pathlength- corrected estimates of absolute Hb/Mb concentrations and blood flow index (BFi), allowing for the extraction of tissue regional oxygen metabolic rate (MRO2i), a parameter directly linked to oxygen utilization. We hypothesize that wbDOS and DCS measurements can be acquired simultaneously at high speed (>10 Hz) with parallel detection and integrated electronics. This speed is needed to capture inspiratory/expiratory dynamics at the respiratory rate. Additionally, we hypothesize wideband frequency-domain DOS measurements will provide improved quantification of optical properties, BFi and MRO2i when optically integrated with DCS as compared to single frequency FD-DOS or CW-NIRS. We will validate this through rigorous system testing using flow-channel tissue-mimicking optical phantoms. A multi-layer inverse model will be developed to better capture inspiratory muscle metabolism by accounting for subcutaneous lipid thickness and skin tones. We will also expand on our recent work in Deep Neural Network (DNN) processing to develop high-speed algorithms for calculating Hb/Mb concentrations, StO2 (%), BFi (mm2/s), and MRO2i at 10 Hz. We will conduct a feasibility study (n=10) of healthy volunteers during respiratory muscle loading and unloading to evaluate performance compared to expected trends. It is anticipated that completion of these aims will yield a novel and comprehensive blood flow index, oxygenation, and metabolic measurement platform (wbDOS-DCS) and lead to subsequent R01-scale funding.

IC Name
NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING
  • Activity
    R21
  • Administering IC
    EB
  • Application Type
    1
  • Direct Cost Amount
    150000
  • Indirect Cost Amount
    65000
  • Total Cost
    215000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    286
  • Ed Inst. Type
    BIOMED ENGR/COL ENGR/ENGR STA
  • Funding ICs
    NIBIB:215000\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ITD
  • Study Section Name
    Imaging Technology Development Study Section
  • Organization Name
    BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
  • Organization Department
    ENGINEERING (ALL TYPES)
  • Organization DUNS
    049435266
  • Organization City
    BOSTON
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    022151390
  • Organization District
    UNITED STATES